How to Value a Pre-Revenue Biotech Startup

It is difficult to value a biotech startup with no revenues. Unlike e-commerce or SaaS, early biotech companies tend to rely on intellectual property and clinical potential. The most popular techniques are Risk-Adjusted Net Present Value Venture Capital Method, and Scorecard Valuation. future cash flows by clinical success probabilities at every stage.

#BiotechValuation #StartupValuation #HealthcareInvesting #LifeSciencesFunding